Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
Companies
» Company Monitoring Page for Bluebird-Bio
Company Monitoring Page for Bluebird-Bio
latest headlines for company on cafepharma
Bluebird Extends Cash Runway with $175M Financing to Support Gene Therapy Launch
BioSpace
Tue, 03/19/24 - 11:22 am
Tags:
Bluebird Bio
,
funding
,
sickle cell disease
,
Lyfgenia
Bluebird bio inks first Medicaid coverage agreement for sickle cell gene therapy, signing on with Michigan
Fierce Pharma
Mon, 03/11/24 - 11:33 am
Tags:
Bluebird Bio
,
Michigan
,
lovo-cel
,
Lyfgenia
,
Medicaid
,
sickle cell disease
,
gene therapy
Why Bluebird Bio Stock Dived Into the Red on Tuesday
Motley Fool
Tue, 03/5/24 - 10:18 pm
Tags:
Bluebird Bio
Sickle Cell Gene Therapies Seen as Cost Effective Below $2M Threshold: Study
BioSpace
Tue, 01/23/24 - 11:18 am
Tags:
gene therapy
,
sickle cell disease
,
drug pricing
,
Vertex Pharmaceuticals
,
Bluebird Bio
Bluebird bio's Lyfgenia launch progresses with 2nd major outcomes-based coverage deal
Fierce Pharma
Thu, 01/4/24 - 11:37 am
Tags:
Bluebird Bio
,
Lyfgenia
,
sickle cell disease
,
gene therapy
Bluebird Looks to Raise $250M After Lukewarm Reception of SCD Gene Therapy
BioSpace
Tue, 12/19/23 - 10:21 am
Tags:
Bluebird Bio
,
funding
Bluebird’s Newly Approved SCD Gene Therapy Faces Rough Road with Hefty Price Tag, Boxed Warning
BioSpace
Mon, 12/11/23 - 11:20 am
Tags:
Bluebird Bio
,
sickle cell disease
,
Lyfgenia
,
gene therapy
,
CRISPR
FDA approves bluebird's sickle cell disease gene therapy. Can Lyfgenia overcome CRISPR's halo?
Fierce Pharma
Sun, 12/10/23 - 11:15 pm
Tags:
Bluebird Bio
,
sickle cell disease
,
FDA
,
CRISPR
,
Lyfgenia
Bluebird won't play off Vertex in deciding price for its lovo-cel gene therapy, exec says
Fierce Pharma
Tue, 11/7/23 - 11:02 pm
Tags:
Bluebird Bio
,
Vertex Pharmaceuticals
,
exa-cel
,
lovo-cel
,
sickle cell disease
,
drug pricing
Two Sickle Cell Disease Gene Therapies May Soon Be Approved By FDA
Forbes
Thu, 11/2/23 - 05:07 pm
Tags:
sickle cell disease
,
gene therapy
,
lovo-cel
,
exa-cel
,
Vertex Pharmaceutical
,
CRISPR Therapeutics
,
Bluebird Bio
Bluebird bio to sell sickle cell FDA voucher for $103 mln if therapy approved
Reuters
Mon, 10/30/23 - 10:23 am
Tags:
Bluebird Bio
,
priority review vouchers
,
sickle cell disease
,
gene therapy
5 FDA decisions to watch in the fourth quarter
BioPharma Dive
Mon, 10/2/23 - 12:00 pm
Tags:
FDA
,
Alnylam
,
Onpattro
,
ATTR amyloidosis
,
Vertex Pharmaceuticals
,
CRISPR Therapeutics
,
exa-cel
,
Bluebird Bio
,
Zynteglo
,
sickle cell disease
,
Bristol Myers Squibb
,
2seventy bio
,
Abecma
,
Multiple Myeloma
,
Amgen
,
Lumakras
,
non-small cell lung cancer
,
Pfizer
,
estrasimod
,
ulcerative colitis
Bluebird taps Lonza to boost manufacturing capacity for its gene therapies Zynteglo, Skysona
Fierce Pharma
Thu, 09/28/23 - 10:27 am
Tags:
Bluebird Bio
,
gene therapy
,
Lonza
,
drug manufacturing
,
CDMOs
Bluebird’s Lovo-Cel Gene Therapy for SCD Will Not Face FDA Adcomm
BioSpace
Wed, 08/16/23 - 11:09 pm
Tags:
Bluebird Bio
,
sickle cell disease
,
lovo-cel
,
FDA
Bluebird touts Zynteglo, Skysona launch progress as FDA decision on sickle cell therapy nears
Fierce Pharma
Tue, 08/8/23 - 11:33 am
Tags:
Bluebird Bio
,
Zynteglo
,
Skysona
,
FDA
,
sickle cell disease
,
gene therapy
U.S. watchdog lifts price estimate for Bluebird, Vertex/CRISPR gene therapies to $2.1 million
Reuters
Fri, 07/14/23 - 10:07 am
Tags:
ICER
,
gene therapy
,
Vertex Pharmaceuticals
,
CRISPR Therapeutics
,
Bluebird Bio
,
drug pricing
,
sickle cell disease
9 Highly Anticipated FDA Decisions in Second Half of 2023
BioSpace
Fri, 06/30/23 - 11:52 am
Tags:
FDA
,
Eisai
,
Biogen
,
Leqembi
,
Alzheimer's disease
,
SAGE Therapeutics
,
zuranolone
,
postpartum depression
,
major depressive disorder
,
Roche
,
Tecentriq
,
non-small cell lung cancer
,
CRISPR Therapeutics
,
Bluebird Bio
,
lovo-cel
,
exa-cel
,
BrainStorm Cell Therapeutics
,
NurOwn
Bluebird, playing catch-up, gets decision date for sickle cell gene therapy
BioPharma Dive
Wed, 06/21/23 - 11:49 am
Tags:
Bluebird Bio
,
gene therapy
,
sickle cell disease
,
lovo-cel
,
FDA
Death triggers pause of 2seventy CAR-T cell therapy leukemia trial
Fierce Biotech
Wed, 06/14/23 - 10:18 am
Tags:
2seventy bio
,
Bluebird Bio
,
CAR-T
,
patient death
,
clinical trials
,
AML
Gene Therapies Are Still Hampered By Substantial Delays Between Approval And Launch
Forbes
Wed, 05/3/23 - 11:48 am
Tags:
gene therapy
,
drug approvals
,
Biomarin
,
Bluebird Bio
,
FDA
Pages
1
2
3
4
5
6
7
8
9
…
next ›
last »
last 30 twitter posts
current feelings about your job
job rating
*
1 - I hate my job
2
3
4
5
6
7 - I love my job
Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
please tell us why
*
your industry
*
your job title (optional)
your company
*
published
N/A
published
not published
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
a dog would most likely chase a: cat, rock, house
*
Fill in the blank.